Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
28.89
+0.24 (0.84%)
Aug 14, 2025, 2:03 PM - Market open
Twist Bioscience Revenue
Twist Bioscience had revenue of $96.06M in the quarter ending June 30, 2025, with 17.91% growth. This brings the company's revenue in the last twelve months to $362.27M, up 22.72% year-over-year. In the fiscal year ending September 30, 2024, Twist Bioscience had annual revenue of $312.97M with 27.69% growth.
Revenue (ttm)
$362.27M
Revenue Growth
+22.72%
P/S Ratio
4.69
Revenue / Employee
$392,495
Employees
923
Market Cap
1.74B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
TWST News
- 1 day ago - Twist Bioscience: Headwinds Are Mounting - Seeking Alpha
- 8 days ago - Twist Bioscience Appoints Trynka Shineman Blake to Board of Directors - Business Wire
- 9 days ago - Twist Bioscience Turns The Tide: Q3 Sales Jump, Beats Earnings - Benzinga
- 10 days ago - Twist Bioscience Corporation (TWST) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 10 days ago - Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results - Business Wire
- 14 days ago - Twist Bioscience Expands In Vivo Antibody Discovery Services with Launch of Humanized Transgenic Mouse Model - Business Wire
- 21 days ago - Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Business Wire
- 4 weeks ago - Twist Bioscience: Still Not There Yet - Seeking Alpha